{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:57:50Z","timestamp":1790632670976,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.xops.2023.100278","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T22:02:18Z","timestamp":1675375338000},"page":"100278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["High Levels of C-Reactive Protein with Low Levels of Pentraxin 3 as Biomarkers for Central Serous Chorioretinopathy"],"prefix":"10.1016","volume":"3","author":[{"given":"Elodie","family":"Bousquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Chenevier-Gobeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thara","family":"Jaworski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lo\u00efse","family":"Torres-Villaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Zola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irmela","family":"Mantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kowalczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Matet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Daruich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Yzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8571-9513","authenticated-orcid":false,"given":"Francine","family":"Behar-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2023.100278_bib1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","article-title":"Central serous chorioretinopathy: recent findings and new physiopathology hypothesis","volume":"48","author":"Daruich","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2023.100278_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41433-018-0158-4","article-title":"Pachychoroid disease","volume":"33","author":"Cheung","year":"2019","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2023.100278_bib3","first-page":"1706","article-title":"Clinical characteristics and multimodal imaging findings of central serous chorioretinopathy in women versus men","volume":"11","author":"Bousquet","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.xops.2023.100278_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100973","article-title":"Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders","volume":"86","author":"Spaide","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2023.100278_bib5","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1167\/iovs.18-23995","article-title":"Choroidal vascular reactivity in central serous chorioretinopathy","volume":"59","author":"Cardillo Piccolino","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2023.100278_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0039-6257(02)00338-7","article-title":"Central serous chorioretinopathy and glucocorticoids","volume":"47","author":"Bouzas","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.xops.2023.100278_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajo.2016.02.012","article-title":"Shift work: a risk factor for central serous chorioretinopathy","volume":"165","author":"Bousquet","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2023.100278_bib8","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1097\/IAE.0000000000002702","article-title":"The association between central serous chorioretinopathy and sleep apnea: a nationwide population-based study","volume":"40","author":"Liu","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.xops.2023.100278_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100865","article-title":"Central serous chorioretinopathy: an update on risk factors, pathophysiology and imaging modalities","volume":"79","author":"Kaye","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2023.100278_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000362724","article-title":"One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids","volume":"22","author":"Cruz-Topete","year":"2015","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.xops.2023.100278_bib11","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1111\/bph.15770","article-title":"Mineralocorticoid pathway in retinal health and diseases","volume":"179","author":"Behar-Cohen","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.xops.2023.100278_bib12","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":"Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy","volume":"122","author":"Zhao","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.xops.2023.100278_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77202-y","article-title":"Lipocalin 2 as a potential\u00a0systemic biomarker for central serous chorioretinopathy","volume":"10","author":"Matet","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2023.100278_bib14","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1177\/11206721221089773","article-title":"Elevated serum fibrinogen\/albumin ratios in patients with acute central serous chorioretinopathy","volume":"32","author":"Limon","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.xops.2023.100278_bib15","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1111\/aos.14547","article-title":"Altered plasma cytokine levels in acute and chronic central serous chorioretinopathy","volume":"99","author":"Karska-Basta","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.xops.2023.100278_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-immunol-030409-101305","article-title":"An integrated view of humoral innate immunity: pentraxins as a paradigm","volume":"28","author":"Bottazzi","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.xops.2023.100278_bib17","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.3389\/fimmu.2019.01750","article-title":"Regulation of the complement system by pentraxins","volume":"10","author":"Haapasalo","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.xops.2023.100278_bib18","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.3389\/fimmu.2020.02126","article-title":"How C-reactive protein structural isoforms with distinctive bioactivities affect disease progression","volume":"11","author":"Rajab","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.xops.2023.100278_bib19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1515\/CCLM.2009.110","article-title":"Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations","volume":"47","author":"Yamasaki","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.xops.2023.100278_bib20","doi-asserted-by":"crossref","first-page":"29983","DOI":"10.1074\/jbc.M805631200","article-title":"Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and nonhematopoietic cells","volume":"283","author":"Doni","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.xops.2023.100278_bib21","doi-asserted-by":"crossref","unstructured":"Chhablani J, Behar-Cohen F, Central Serous Chorioretinopathy International Group. Validation of central serous chorioretinopathy multimodal imaging-based classification system. Graefes Arch Clin Exp Ophthalmol. 2022;260:1161\u20131169. doi:10.1007\/s00417-021-05452-1.","DOI":"10.1007\/s00417-021-05452-1"},{"key":"10.1016\/j.xops.2023.100278_bib22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jamaophthalmol.2013.2303","article-title":"C-reactive protein and the incidence of macular degeneration: pooled analysis of 5 cohorts","volume":"131","author":"Mitta","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2023.100278_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.molimm.2022.04.003","article-title":"IL-6 regulates induction of C-reactive protein gene expression by activating STAT3 isoforms","volume":"146","author":"Ngwa","year":"2022","journal-title":"Mol Immunol"},{"key":"10.1016\/j.xops.2023.100278_bib24","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.numecd.2006.05.001","article-title":"C-reactive protein in hypertension: clinical significance and predictive value","volume":"16","author":"Schillaci","year":"2006","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.xops.2023.100278_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom Med"},{"key":"10.1016\/j.xops.2023.100278_bib26","article-title":"Is C-reactive protein a marker of obstructive sleep apnea?: A meta-analysis","volume":"96","author":"Li","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.xops.2023.100278_bib27","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2147\/TCRM.S138581","article-title":"Neutrophil\/lymphocyte ratio and mean platelet volume in central serous chorioretinopathy","volume":"13","author":"Erol","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.xops.2023.100278_bib28","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1167\/iovs.17-21825","article-title":"Peripheral vascular endothelial dysfunction in central serous chorioretinopathy","volume":"58","author":"Wang","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2023.100278_bib29","doi-asserted-by":"crossref","first-page":"854","DOI":"10.4103\/ijo.IJO_1327_19","article-title":"Monocyte to high-density lipoprotein and neutrophil-to-lymphocyte ratios in patients with acute central serous chorioretinopathy","volume":"68","author":"Sirakaya","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.xops.2023.100278_bib30","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1074\/jbc.272.13.8172","article-title":"Characterization of the promoter for the human long pentraxin PTX3. Role of NF-kappaB in tumor necrosis factor-alpha and interleukin-1beta regulation","volume":"272","author":"Basile","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.xops.2023.100278_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/09273948.2014.891755","article-title":"Elevated plasma pentraxin3 levels and its association with neovascular age-related macular degeneration","volume":"23","author":"Min","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.xops.2023.100278_bib32","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/IAE.0b013e3182993d74","article-title":"PENTRAXIN 3 and other inflammatory factors in central retinal vein occlusion and macular edema","volume":"34","author":"Noma","year":"2014","journal-title":"Retina. PA"},{"key":"10.1016\/j.xops.2023.100278_bib35","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1167\/iovs.14-14864","article-title":"Elevated plasma PENTRAXIN 3 levels are associated with development and progression of diabetic retinopathy in Korean patients with type 2 diabetes mellitus","volume":"55","author":"Yang","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2023.100278_bib36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jb\/mvu086","article-title":"Glucocorticoid augments lipopolysaccharide-induced activation of the I\u03baB\u03b6-dependent genes encoding the anti-microbial glycoproteins lipocalin 2 and PENTRAXIN 3","volume":"157","author":"Yamazaki","year":"2015","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.xops.2023.100278_bib37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000489125","article-title":"Evaluation of hypothalamic-pituitary-adrenal axis suppression following cutaneous use of topical corticosteroids in children: A meta-analysis","volume":"89","author":"Wood Heickman","year":"2018","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.xops.2023.100278_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13165","article-title":"Corticotroph isolation from Pomc-EGFP mice reveals sustained transcriptional dysregulation characterising a mouse model of glucocorticoid-induced suppression of the hypothalamus-pituitary-adrenal axis","volume":"34","author":"Duncan","year":"2022","journal-title":"J\u00a0Neuroendocrinol"},{"key":"10.1016\/j.xops.2023.100278_bib39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.semarthrit.2016.03.001","article-title":"Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review","volume":"46","author":"Joseph","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.xops.2023.100278_bib40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJM199201233260403","article-title":"The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone","volume":"326","author":"Schlaghecke","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xops.2023.100278_bib41","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3390\/diagnostics11040728","article-title":"Glucocorticoid withdrawal-an overview on when and how to diagnose adrenal insufficiency in clinical practice","volume":"11","author":"Pelewicz","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.xops.2023.100278_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132800","article-title":"Systemic and ocular long PENTRAXIN 3 in patients with age-related macular degeneration","volume":"10","author":"Juel","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.xops.2023.100278_bib43","first-page":"303","article-title":"Human retinal pigment epithelial cells express the long pentraxin PTX3","volume":"19","author":"Woo","year":"2013","journal-title":"Mol Vis"},{"key":"10.1016\/j.xops.2023.100278_bib44","article-title":"Inhibition of proliferation and epithelial mesenchymal transition in retinal pigment epithelial cells by heavy chain-hyaluronan\/PENTRAXIN 3","volume":"7","author":"He","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2023.100278_bib45","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/path.4811","article-title":"PENTRAXIN 3 recruits complement factor H to protect against oxidative stress-induced complement and inflammasome overactivation","volume":"240","author":"Wang","year":"2016","journal-title":"J\u00a0Pathol"},{"issue":"12","key":"10.1016\/j.xops.2023.100278_bib46","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00109-018-1698-6","article-title":"PENTRAXIN 3 promotes long-term cerebral blood flow recovery, angiogenesis, and neuronal survival after stroke","volume":"96","author":"Rajkovic","year":"2018","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.xops.2023.100278_bib47","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/CIRCULATIONAHA.108.806547","article-title":"Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis","volume":"120","author":"Norata","year":"2009","journal-title":"Circulation"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914523000106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914523000106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:25:06Z","timestamp":1763015106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914523000106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2666914523000106"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2023.100278","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Levels of C-Reactive Protein with Low Levels of Pentraxin 3 as Biomarkers for Central Serous Chorioretinopathy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2023.100278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100278"}}